PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…</p><p>FDA-approved and off-label medications used for PTSD treatment did not yield a consistently greater CAPS decrease vs. control arms across trials. …”

PRISMA flow chart. by Filip Stanicic (17808254)

“…</p><p>FDA-approved and off-label medications used for PTSD treatment did not yield a consistently greater CAPS decrease vs. control arms across trials. …”

Ethnic identity as a moderator among APIDA students. by Ronna Bañada (19233063)

Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

Study-related adverse events. by Benjamin R. Lewis (22279166)

“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”

Study flow chart. by Benjamin R. Lewis (22279166)

“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”

Development of alpha diversity across weeks towards a new TNF treatment for each IBD disease subtype. by Katrine Carlsen (5477300)

Gross photography and construct weight for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Transcriptional analysis of chondrogenic and osteogenic genes. by Melissa A. MacIver (12850566)

S1 Data - by Marc S. Penn (16624541)

“…During follow-up, a 100 pmol/L decrease in MPO correlated with a 5% reduction in mortality (HR, 0.95; 95% CI, 0.93–0.97) over 5 years.…”

Fig 2 - by Marc S. Penn (16624541)

Fig 1 - by Marc S. Penn (16624541)

Capabilities expansion scenarios considered. <i><i>g</i></i>_GDP and <i><i>g</i></i>_fHE refer to the growth rate of annual GDP (in constant 2015 US$) and growt... by Margherita Molaro (17803989)

DataSheet_1_Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

Map of Harlingen, TX showing the location of the four study neighborhoods. by Jesús A. Aguilar-Durán (9931967)

<i>Aedes aegypti</i> database from SAGO traps. by Jesús A. Aguilar-Durán (9931967)

“…</p><p>Conclusion</p><p>Despite all treatments followed a reduction in mosquito populations, those that included AGO showed a greater decrease in post treatment populations than conventional control measures (IVM) alone. …”

Weather conditions and variation in the numbers of female <i>Ae. aegypti</i> captured in SAGO traps. by Jesús A. Aguilar-Durán (9931967)

Average number of female <i><i>Ae</i></i>. <i><i>aegypti</i></i> in SAGOs traps per trap per week before and after treatments. by Jesús A. Aguilar-Durán (9931967)

<b>Nest mass in forest tits </b><b><i>Paridae</i></b><b> </b><b>increases with elevation and decreasing body mass, promoting reproductive success</b> by Clara Wild (19246606)

“…We predicted that nest mass should increase with elevation and canopy openness, due to thermoregulation being more demanding in colder or warmer climatic conditions, and decrease with body mass, as larger species have greater thermoregulatory capabilities. …”